Abstract Number: 2055 • 2012 ACR/ARHP Annual Meeting
TEAM-Managed Care of Biological Patients At A Canadian Centre
Background/Purpose: Managing complex arthritic patients with biologics is exacting and time consuming. As a result in January 2008 we established a separate biologic clinic with…Abstract Number: 2056 • 2012 ACR/ARHP Annual Meeting
Effectiveness of a Focused Educational Intervention in Improving the Supplementation of Vitamin D Deficiency and Insufficiency
Background/Purpose: Vitamin D deficiency and insufficiency are important clinical states with the potential for adverse skeletal and non-skeletal consequences. In our experience the management of…Abstract Number: 2057 • 2012 ACR/ARHP Annual Meeting
Analysis of the Adherence to the Monitoring of Glucocorticoid Eye Toxicity and of the Prevalence of Cataracts and Glaucoma Among Patients with Systemic Lupus Erythematosus
Background/Purpose: Cataracts and glaucoma are among the main causes of impaired visual acuity and have a prevalence respectively of 9-17% and 1-2% among subjects older…Abstract Number: 2058 • 2012 ACR/ARHP Annual Meeting
Differences in Psychological Characteristics Between Patients with Rheumatoid and Psoriatic Arthritis
Background/Purpose: Both rheumatoid (RA) and psoriatic arthritis (PsA) seem to have a negative impact on patients’ psychological status mostly due to the chronic character of…Abstract Number: 2059 • 2012 ACR/ARHP Annual Meeting
The Efficacy of Clinical Guidelines in Promoting Co-Prescription of Bone Protection with Glucocorticoids Among Hospital Doctors Treating Inpatients
Background/Purpose: Therapeutic glucocorticoids (GC) rapidly decrease bone mineral density, inducing a remodelling imbalance by promoting osteoclast differentiation and activation and by inhibiting oscteocytes. Current guidelines…Abstract Number: 2060 • 2012 ACR/ARHP Annual Meeting
Using the Electronic Medical Record to Increase Rates of Physician Assessment of Lipids in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Quality Improvement Initiative
Background/Purpose: Cardiovascular disease (CVD) is a major cause of morbidity and mortality in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Guidelines for the management…Abstract Number: 2020 • 2012 ACR/ARHP Annual Meeting
Assessment of Procedure Safety and Cannula Position in Temporomandibular Joint Puncture Evaluated by Cone Beam Computerized Tomography
Background/Purpose: Temporomandibular joint (TMJ) arthritis frequently occurs in juvenile idiopathic arthritis (JIA). Only sparse information is available concerning the inflammatory activity and the underlying biology…Abstract Number: 2021 • 2012 ACR/ARHP Annual Meeting
The Schedule of Administration of Canakinumab in Cryopyrin Associated Periodic Syndrome Is Driven by the Phenotype Severity Rather Than the Age
Background/Purpose: to identify the optimal regimen for the treatment with Canakinumab in CAPS patients and, in patients receiving both Anakinra and Canakinumab during their disease…Abstract Number: 2022 • 2012 ACR/ARHP Annual Meeting
Individual Disease Burden in Children and Adolescents with Chronic Musculoskeletal Pain – Multilevel-Analysis of a Nationwide Prospective Longitudinal Observation Study
Background/Purpose: Chronic musculoskeletal pain was described to be a frequent complaint in children and adolescents with assumed relevant impairment of health-related quality of life (HRQoL)…Abstract Number: 2023 • 2012 ACR/ARHP Annual Meeting
Should Joint Ultrasound Contribute to Therapeutic Decisions in Juvenile Idiopathic Arthritis?
Background/Purpose: Over several years, numerous studies have been published on the interest of joint ultrasound in juvenile idiopathic arthritis. Several authors have demonstrated that ultrasonography…Abstract Number: 2024 • 2012 ACR/ARHP Annual Meeting
Articular Symptoms in Cryopyrin-Associated Periodic Syndrome: Retrospective French Study
Background/Purpose: The cryopyrin-associated periodic syndrome (CAPS) is a rare inherited inflammatory disease associated with a mutation in the NLRP3 gene. Articular symptoms are often described…Abstract Number: 2025 • 2012 ACR/ARHP Annual Meeting
Clinical Characteristics and Therapy Response in a Large Single-Centre Cohort of Patients with Periodic Fever with Aphtous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome
Background/Purpose: PFAPA (Period Fever with Aphtous stomatitis, Pharyngitis and cervical Adenitis), is a periodic syndrome described for the first time in 1987 by Marshall et…Abstract Number: 2026 • 2012 ACR/ARHP Annual Meeting
High Prevalence of Cervical Spine and Temporomandibular Joint Involvement in Patients with Juvenile Idiopathic Arthritis
Background/Purpose: Detection of involvement of temporomandibular joints (TMJ), which are frequently affected by juvenile idiopathic arthritis (JIA), is only possible on Gadolinium enhanced MRI…Abstract Number: 2027 • 2012 ACR/ARHP Annual Meeting
Chronic Nonbacterial Osteomyelitis of the Mandible in Children: a Tertiary Center Experience
Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) of the mandible is a rare osseous autoinflammatory disease. Diagnosis is based on characteristic clinical, laboratory and imaging features. Our…Abstract Number: 2028 • 2012 ACR/ARHP Annual Meeting
Medication Adherence and Quality of Life in Children with Rheumatic Disease
Background/Purpose: Children with rheumatic diseases are often prescribed complex medication regimens. Medication side-effects may have a negative impact on physical appearance and subsequently impact adherence. …